Moreover, checkpoint inhibitor or immune agonist treatment of MM patient’ (N = 5) BMMC increased Treg proliferation, with a significantly (*p < 0.05) high induction by anti-PD1 or anti-OX40 and the lowest induction by anti-LAG3 (Fig. 5B; histograms, bar graph). This evidence concerns the gene TNFRSF4 and Miyoshi myopathy.